https://adisinsight.springer.com/drugsafety/803374667?error=cookies_not_supported&code=72a68977-06f6-499c-8d51-140478246c8a
Cisplatin/gimeracil/oteracil/tegafur - AdisInsight
A 71-year-old man developed anorexia and elevated ALP level during treatment with cisplatin and gimeracil/oteracil/tegafur [S-1] for an advanced gastric
cisplatinadisinsight
https://adisinsight.springer.com/drugsafety/803924360?error=cookies_not_supported&code=1bf9cef3-f6e2-42a1-902c-8dc45ad755cc
Gemcitabine/Gimeracil/oteracil/tegafur - AdisInsight
Patients with postoperative pancreatic ductal adenocarcinoma received adjuvant therapy with either gemcitabine and S-1 (gimeracil/oteracil/tegafur) or S-1
gemcitabineadisinsight
https://adisinsight.springer.com/drugsafety/803123706?error=cookies_not_supported&code=233013a9-e08d-4856-9531-0e4a4c8298fe
Gimeracil/oteracil/tegafur - AdisInsight
From a retrospective study five patients [ages and sexes not stated] were identified who developed diarrhoea, gastric ulcer, fatigue or cholangitis following
adisinsight
https://adisinsight.springer.com/drugsafety/803929817?error=cookies_not_supported&code=a4984310-b3d4-489a-bb83-d7b07b98dfcd
Gimeracil/oteracil/tegafur - AdisInsight
A 72-year-old woman with poorly differentiated adenocarcinoma classified as cancer of unknown primary and a separate well-differentiated gastric adenocarcinoma
adisinsight
https://adisinsight.springer.com/drugsafety/803914642?error=cookies_not_supported&code=fe2002f2-fad7-49e8-b369-8a094c07dfa3
Capecitabine/Gimeracil/oteracil/tegafur/Oxaliplatin - AdisInsight
A retrospective study included 22 patients with stage IV gastric cancer and gastric outlet obstruction who underwent modified laparoscopic stomach-partitioning
capecitabineoxaliplatinadisinsight
https://adisinsight.springer.com/drugsafety/803927735?error=cookies_not_supported&code=64041934-4fca-4e0f-b16f-b2aad022abb9
Docetaxel/Gimeracil/oteracil/tegafur/Oxaliplatin - AdisInsight
Thirty-seven patients [sex not stated] aged [age not stated] with resectable gastroesophageal junction adenocarcinoma received neoadjuvant docetaxel 60 mg/m2
docetaxeloxaliplatinadisinsight
https://adisinsight.springer.com/drugsafety/803606894?error=cookies_not_supported&code=af8e8922-a790-47a1-ae42-e6f7f94f5fb3
Gimeracil/oteracil/tegafur/sorafenib - AdisInsight
In a prospective cohort study involving 12 patients with advanced hepatocellular carcinoma conducted between July 2011 and June 2015 in Japan, a patient [age
sorafenibadisinsight
https://adisinsight.springer.com/drugsafety/803118282?error=cookies_not_supported&code=1457e83a-5013-4c14-b18e-a50af28a9ddf
Gimeracil/oteracil/tegafur - AdisInsight
A 73-year-old man developed leucopenia, neutropenia, anaemia and thrombocytopenia while receiving gimeracil/oteracil/tegafur.The man had a history of stage IVa
adisinsight